Results 101 to 110 of about 7,292 (203)

Renin-angiotensin system and minoxidil-induced cardiac hypertrophy in rats

, 1993
Besides cardiac volume overload, cardiac sympathetic activity and the renin-angiotensin system (RAS) are activated by arterial vasodilators such as minoxidil.
F. H. Leenen, M. Ruzicka
core   +1 more source

[Hypertrichosis during treatment with minoxidil]

, 1985
21 patients afflicted with severe arterial hypertension have been observed and followed for a period of five months to find the cause of hypertrichosis.
G. C. Ambroso, T. Povia, P. L. Bencini, F. Sala, C. Crosti   +4 more
core  

Xerostomia as a Rare Adverse Effect of Low‐Dose Oral Minoxidil: A Case Report With Recurrence After Rechallenge

Clinical Case Reports
Low‐dose oral minoxidil (LDOM) is an emerging option for the treatment of female pattern hair loss (FPHL), generally well tolerated at doses under 1 mg/day.
Nicolò Rivetti
doaj   +1 more source

Minoxidil Sulfotransferase, a Marker of Human Keratinocyte Differentiation

, 1992
The sulfation of minoxidil is catalyzed by a sulfotransferase activity in a number of tissues including skin. To investigate further the nature of the minoxidil sulfotransferase activity in epithelial tissue and to compare this activity to that of ...
Johnson, Garland A, Knight, Karen A, Baker, Carolyn A   +2 more
core   +1 more source

Effects of Minoxidil Gel on Burn Wound Healing in Rats [PDF]

Minoxidil has been reported to inhibit in-vitro fibroblast proliferation and lysyl hydroxylase activity, a key enzyme in collagen biosynthesis. These in-vitro effects proposed minoxidil to be a potential antifibrotic agent.
Khazaelia, Payam, Sadeghiradd, Behnam, Karamouzianb, Mohammad, Rohani, Shohreh, Ghalekhani, Nima   +4 more
core  

Combating Dread Shed : The Impact of Overlapping Topical and Oral Minoxidil on Temporary Hair Shedding During Oral Minoxidil Initiation

BACKGROUND: Low dose oral minoxidil (LDOM) is a preferred treatment for alopecia due to ease of use and efficacy. While LDOM is typically well tolerated, patients may experience a temporary increase in hair shedding starting treatment, colloquially ...
Sikora, Michelle, Lo Sicco, Kristen, Shapiro, Jerry, Nohria, Ambika, Mandal, Soutrik, Desai, Deesha   +5 more
core   +1 more source

Applications and efficacy of minoxidil in dermatology

Minoxidil, originally developed as an antihypertensive medication, has evolved into a versatile therapeutic agent within dermatology, notably for its effectiveness in promoting hair growth.
Abeer Ali El‐Sherbiny, Salman Bin Dayel, Ramadan S. Hussein, Othman Abahussein   +3 more
core   +1 more source

Bicalutamide 25 mg combined with minoxidil 1 mg versus minoxidil 1 mg for female pattern hair loss: A randomized double-blind clinical trial

Background: Antiandrogenic drugs are often used to treat female pattern hair loss (FPHL) despite limited evidence supporting their use. There is growing interest in bicalutamide for this purpose, but its efficacy in treating FPHL has not been evaluated ...
Motta, Adriana Viana da, Libório, Ricardo da Silva [UNESP], Müller Ramos, Paulo [UNESP], Miot, Hélio Amante [UNESP]   +3 more
core   +1 more source

Topical Minoxidil and Low-Dose Oral Minoxidil in Onychodystrophy: A Proposed Treatment Algorithm. [PDF]

J Cosmet Dermatol
Gupta AK, Talukder M, Lipner SR.
europepmc   +1 more source

Efficacy and Safety of Fractional Laser Therapy for Androgenetic Alopecia: A Systematic Review and Meta-Analysis. [PDF]

J Cosmet Dermatol
Chen C, Wang S, Bi D, Wei AC, Guo S.
europepmc   +1 more source